P3 Health Partners Future Growth
Future criteria checks 1/6
P3 Health Partners is forecast to grow earnings and revenue by 88.7% and 15.2% per annum respectively while EPS is expected to grow by 79% per annum.
Key information
88.7%
Earnings growth rate
79.0%
EPS growth rate
| Healthcare earnings growth | 19.3% |
| Revenue growth rate | 15.2% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 09 Aug 2024 |
Recent future growth updates
Recent updates
Health Check: How Prudently Does P3 Health Partners (NASDAQ:PIII) Use Debt?
Aug 26
P3 Health Partners: Moving In The Right Direction In 2024
Jun 07P3 Health Partners GAAP EPS of -$3.73, revenue of $269.45M
Oct 20P3 Health gets Nasdaq notice for delisting, plans appeal
Oct 05P3 Health expands Nevada footprint with acquisition of Pahrump cardiology practice
Aug 29P3 Health Partners receives Nasdaq notice for non-compliance
Aug 19Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 2,104 | 15 | N/A | N/A | 1 |
| 12/31/2025 | 1,750 | -19 | 61 | 66 | 4 |
| 12/31/2024 | 1,521 | -39 | -6 | -1 | 4 |
| 6/30/2024 | 1,403 | -69 | -54 | -54 | N/A |
| 3/31/2024 | 1,353 | -67 | -74 | -72 | N/A |
| 12/31/2023 | 1,266 | -58 | -78 | -76 | N/A |
| 9/30/2023 | 1,178 | -126 | -94 | -92 | N/A |
| 6/30/2023 | 1,138 | -124 | -108 | -105 | N/A |
| 3/31/2023 | 1,078 | -269 | -124 | -122 | N/A |
| 12/31/2022 | 1,049 | -270 | -128 | -126 | N/A |
| 9/30/2022 | 977 | -100 | -123 | -121 | N/A |
| 6/30/2022 | 884 | -121 | -108 | -105 | N/A |
| 3/31/2022 | 760 | 4 | -85 | -81 | N/A |
| 12/31/2021 | 637 | -10 | -70 | -66 | N/A |
| 9/30/2021 | 582 | -90 | -61 | -58 | N/A |
| 6/30/2021 | 555 | -74 | -57 | -54 | N/A |
| 3/31/2021 | 527 | -49 | -43 | -40 | N/A |
| 12/31/2020 | 491 | -31 | -28 | -25 | N/A |
| 12/31/2019 | 145 | -42 | -30 | -28 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PIII is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: PIII is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: PIII is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: PIII's revenue (15.2% per year) is forecast to grow faster than the US market (8.8% per year).
High Growth Revenue: PIII's revenue (15.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PIII's Return on Equity is forecast to be high in 3 years time